Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gilead | NASDAQ | Healthcare | Pharmaceuticals | $98.01B | 93.1x | -1.15 | $78.72 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Astellas Pharma Inc | OTC Markets | Healthcare | Pharmaceuticals | $22.69B | 150.4x | -1.88 | $12.40 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0% Upside | Upgrade to Pro+ | |
Adobe | NASDAQ | Technology | Software & IT Services | $249.82B | 50.3x | 8.12 | $563.41 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.7% Upside | Upgrade to Pro+ | |
Bristol-Myers Squibb | NYSE | Healthcare | Pharmaceuticals | $98.73B | -15.1x | 0.08 | $48.70 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
Novartis | OTC Markets | Healthcare | Pharmaceuticals | $236.77B | 14.9x | 0.2 | $116.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.6% Downside | Upgrade to Pro+ | |
London Stock Exchange ADR | OTC Markets | Financials | Investment Banking & Investment Services | $70.82B | 81.2x | -2.08 | $33.80 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.8% Upside | Upgrade to Pro+ | |
Novartis ADR | NYSE | Healthcare | Pharmaceuticals | $236.77B | 14.9x | 0.2 | $116.65 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.3% Upside | Upgrade to Pro+ | |
Expedia | NASDAQ | Consumer Cyclicals | Hotels & Entertainment Services | $17.22B | 22.5x | 18.71 | $132.26 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.6% Upside | Upgrade to Pro+ | |
Intuit | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | $172.41B | 58.3x | 2.44 | $615.12 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Eli Lilly | NYSE | Healthcare | Pharmaceuticals | $812.82B | 111.1x | 8.45 | $902.71 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
AstraZeneca PLC | OTC Markets | Healthcare | Pharmaceuticals | $257.36B | 39.9x | 9.37 | $168.98 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Goldman Sachs | NYSE | Financials | Investment Banking & Investment Services | $159.77B | 15.4x | 0.47 | $479.61 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Mastercard | NYSE | Technology | Software & IT Services | $439.86B | 36.4x | 1.59 | $476.12 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.4% Upside | Upgrade to Pro+ | |
AstraZeneca ADR | NASDAQ | Healthcare | Pharmaceuticals | $257.36B | 39.9x | 9.37 | $83.05 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.5% Upside | Upgrade to Pro+ | |
Daiichi Sankyo ADR | OTC Markets | Healthcare | Pharmaceuticals | $75.41B | 47.3x | 0.84 | $38.65 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Morgan Stanley Pref K | NYSE | Financials | Investment Banking & Investment Services | $156.27B | 15.8x | $25.24 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Discover | NYSE | Financials | Banking Services | $32.31B | 11.4x | -0.52 | $128.68 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
Investor AB | OTC Markets | Financials | Investment Holding Companies | $87.21B | 4.5x | 0.16 | $27.91 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Morgan Stanley Pi ADR | NYSE | Financials | Investment Banking & Investment Services | $156.27B | 15.8x | $25.26 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Goldman Sachs Group Inc Pa ADR | NYSE | Financials | Investment Banking & Investment Services | $159.77B | 15.4x | $23.17 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Goldman Sachs Group Inc Pd ADR | NYSE | Financials | Investment Banking & Investment Services | $159.77B | 15.4x | $22.79 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Meta Platforms | NASDAQ | Technology | Software & IT Services | $1.27T | 24.9x | 0.19 | $500.27 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.4% Upside | Upgrade to Pro+ | |
Raymond James Financial B | NYSE | Financials | Investment Banking & Investment Services | $23.72B | 13.2x | 1.06 | $25.39 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Morgan Stanley Pf ADR | NYSE | Financials | Investment Banking & Investment Services | $156.27B | 15.8x | $25.34 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Salesforce Inc | NYSE | Technology | Software & IT Services | $233.24B | 42x | 0.16 | $243.97 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Morgan Stanley Pe ADR | NYSE | Financials | Investment Banking & Investment Services | $156.27B | 15.8x | $25.36 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Visa A | NYSE | Technology | Software & IT Services | $531.46B | 29.7x | 1.52 | $279.37 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11% Upside | Upgrade to Pro+ | |
Morgan Stanley | NYSE | Financials | Investment Banking & Investment Services | $156.27B | 15.8x | 2.33 | $96.59 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.7% Upside | Upgrade to Pro+ | |
Morgan Stanley Pa ADR | NYSE | Financials | Investment Banking & Investment Services | $156.27B | 15.8x | $22.62 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ashtead Gro | OTC Markets | Industrials | Professional & Commercial Services | $29.72B | 19.1x | -2.94 | $276.67 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.4% Upside | Upgrade to Pro+ |